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Introduction 
Diaphragm disease is found in at least 50% of advanced
stage ovarian cancer patients, more often in the right
hemidiaphragm [1, 2]. Although complete resection of di-
aphragm disease, as it is for other sites of abdominal dis-
ease, has been shown to improve survival [3-5], the
presence of diaphragm metastases is a commonly reported
reason for suboptimal debulking [6-9]. Actually, in a survey
of full members of the Society of Gynecological Oncolo-
gists, 76.3% indicated bulky diaphragm disease was a fac-
tor precluding optimal debulking, and only 24% of
members performed diaphragm resections [10].
Accurate preoperative determination of diaphragm
metastases would be helpful for more accurate blocking of
the operating room time and planning of the operation, as
well as informed consent. A specific surgeon versed in di-
aphragm resection could be requested ahead. 
Present CT images are not sensitive enough for the de-
tection of diaphragm metastases [8, 9] and the gynecologic
oncologist is commonly faced with unexpected diaphragm
disease requiring resection. Proper training in diaphragm
resection should therefore be part of gynecological oncol-
ogists operating patients with ovarian cancer. Also, there
are a limited number of studies correlating surgical find-
ings with CT images specifically for diaphragm metastases
[8, 9]. 
The objective of this study was to correlate surgical find-
ings with pre-operative CT images in ovarian cancer pa-
tients, with and without diaphragm metastases, to assess
the sensitivity and specificity of CT with the intent to fa-
cilitate surgical planning for diaphragm resection. 
Materials and Methods
Retrospective case-control study of 120 patients (60 with and
60 without diaphragm metastases) with EOC, FIGO Stage IIIC or
IV, who underwent cytoreductive surgery at Mayo Clinic, Ari-
zona, between January 2000 and October 2014. The Mayo Clinic
Institutional Review Board approved the study.
All patients had preoperative imaging with CT scan of abdomen
and pelvis, including the lower lung fields, interpreted by mem-
bers of the Department of Radiology specialized in CT imaging.
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Summary
Objective: Correlation of diaphragm surgical findings in ovarian cancer patients with and without diaphragm metastases with pre-op-
erative CT diaphragm findings to assess sensitivity and specificity for diaphragm disease. Material and Methods: A retrospective study
of 120 ovarian cancer patients (60 with and 60 without diaphragm metastases at surgery), FIGO Stage IIIC or IV, undergoing cytore-
ductive surgery at Mayo Clinic, Arizona, between January 2000 and October 2014. All patients had preoperative imaging with CT scan
of abdomen and pelvis including the lower lung fields. CTs were not reviewed retrospectively. Results: Among 60 patients with di-
aphragm metastases, preoperative CTs were positive for diaphragm disease in 17 patients, with a sensitivity rate of 28% (CI 95%: 0.17-
0.41). All 60 patients with no diaphragm metastases had negative CTs, with a specificity of 100% (CI 95%: 94.0%-100%). When
analyzed by lesion size, CTs were negative in 66.7-80% of patients with diaphragm lesions ranging from 1-15 mm. There was a trend
towards increased detection rate with increasing size of lesions, but it did not reach significance (p = 0.529). CT detection rate for sin-
gle metastatic lesion was 18.2% (6/33) and for multiple lesions it was 25.9% (7/27). There was no difference for CT identification of
right, left, or bilateral metastases (p = 0.399). The sensitivity and specificity of CT for pleural effusion was 100% (CI 95%: 72.2%-100%)
and 88% (CI 95%: 76.2%- 94.4%), respectively. The area under the receiver operating characteristic (ROC) curve was 0.680 (CI 95%:
55.3%-72.2%) for CT detection of diaphragm metastases and 0.957 (CI 95%: 79.9%-95.3%) for pleural effusions. Conclusion: CT has
a low sensitivity and a high specificity for the prediction of diaphragm metastases in ovarian cancer. The size, location, and number of
diaphragm lesions do not significantly improve CT detection rate.
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Default slice thickness on the CT scanners was 3.75 mm during
the years of study. 
Data collected included age, BMI, tumor type and grade, FIGO
Stage, pre-operative CT diaphragm results, diaphragm findings at
surgery, and pathology reports. Surgical findings such as lesion
size, number of lesions, peritoneal or full thickness involvement,
and absence of disease were correlated with pre-operative CT scan
findings.
The data was summarized using standard statistical analysis.
Associations were evaluated using chi-square test and Fisher’s
exact test. P values less than 0.05 were considered statistically
significant. Comparisons between the study patients vs. controls
with no diaphragm disease at surgery was conducted using the
non-parameteric Wilcoxon rank sum test to compare for popula-
tion mean shift between two groups for continuous variables, and
the Pearson Chi-squared to test for proportion differences for cat-
egorical variables. The significance level was at 0.05.
Basic measures of performance of diagnostic tests: sensitivity
(positivity in disease) is defined as the number of true positive de-
cisions/the number of actually positive cases, while specificity
(negative in health) is the number of true negative decisions/the
number of actually negative cases. The positive predictive value
(PPV) is defined as the probability of disease for positive test re-
sults, and the negative predictive value (NPV) as the probability
of being healthy for negative test result. Sensitivity and speci-
ficity, the PPV and NPV, and false positive and negative rates
(FPR; FNR) was calculated.
A receiver operating characteristic (ROC) curve and the area
under the ROC curve (AUC) was used to evaluate the perfor-
mance of diagnostic test. In a ROC curve the true positive rate 
(sensitivity) is plotted in function of the FPR (1-specificity) for 
different cut-off points of a parameter. AUC can take on any value 
between 0 and 1, the better result for a diagnostic test was con-
sidered the closet AUC to 1, while the lower limit for the AUC is 
0.5. Statistical Analyses were performed using the statistical soft-
ware packages SAS Studio version 9.3, and R version 3.1.2. 
Results 
A total of 120 patients underwent cytoreductive surgery 
for primary EOC. Sixty of them underwent resection of di-
aphragm metastases and the remaining 60 had no di-
aphragm disease. There were no differences relative to age, 
BMI, FIGO stage, tumor type or tumor grade (Table 1). 
The correlation of diaphragm surgical findings with CT 
scans is shown in Table 2. Preoperative CT images were 
positive for diaphragm disease in 17/60 patients with 
diaphragm metastases, for an overall sensitivity of 28.3%
(CI 95%: 18.5%-40.8%). All 60 patients without 
diaphragm disease at surgery had negative CTs for a 
specificity of 100% (CI 95%: 94.0%-100%). The PPV, 
NPV, and accuracy are shown in Table 2. The ROC curve 
is drawn in Figure 1 (AUC=0.680, CI 95%: 55.3%-72.2%).
The correlation of the location of diaphragm metastases
Table 1. — Demographics, FIGO staging, tumor type, and grade in patients with and without diaphragm metastases. 
Patients with diaphragm metastases Patients without diaphragm metastases p
Age (years) Mean, range (min-max) 63.8 (42.0-78.0) 64.3 (45.0-78.0) NS
BMI, Mean +/- SD 25.9+/-8.83 24.2+/-9.86 NS
FIGO Stage
IIIC 48 (80.0%) 48 (80.0%) NS
IV 12 (20.0%) 12 (20.0%)
Tumor grade
I 1 (1.7%) 0 (0%) NS
II 5 (8.3%) 4 (6.6%)
III 54 (90.0%) 56 (93.4%)
Histological types
Serous 45 (75.0%) 44 (73.3%) NS
Clear cell 4 (6.7%) 4 (6.7%)
Endometrioid 3 (5.0%) 1 (1.7%)
Mucinous 2 (3.3%) 2 (3.3%)
Undifferentiated 1 (1.7%) 0 (0.0%)
Other 5 (8.3%) 9 (15.0%)
%: percentage; SD: standard deviation; BMI: body mass index; p: statistical significance; NS: non significant.
Table 2. — Decision matrix: correlation of diaphragm surgical findings with CT.
Diaphragm metastases at surgery
CT findings Yes, n (%) No, n (%) Total
Positive TP: 17 (28.3%) FP: 0 (0.0%) 17
Negative FN: 43 (71.7%) TN: 60 (100%) 103
Total 60 60 120
Basic measures of performance of diagnostic tests
Sensitivity Specificity PPV NPV Accuracy
95 percent confidence interval
28.3 (18.5-40.8) 100 (94.0-100) 100 (81.6-100) 58.3 (48.6-67.3) 64.2
n: number of patients; %: percentage; TP: true positive; FP: false positive; FN: false negative; TN: true negative.
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at surgery with CT is shown in Table 3. At surgery, the right
diaphragm was involved in 80% (48/60) of patients, fol-
lowed by bilateral involvement in eight (13.3%), and left
diaphragm in four (6.7%) patients. CT was interpreted as
negative in four (50%) of eight patients with bilateral in-
volvement, in all four (100%) patients with left disease, and
in 35 (72.9%) of 48 patients with right metastases. CT cor-
rectly identified diaphragm disease in 50% (4/8) of patients
with bilateral metastases, in ten (20.8%) of 48 patients with
right side disease and in none (0%) of four patients with
left lesions. There was no statistically significant difference
for CT identification of right, left, or bilateral disease (p =
0.399).
The correlation of CT findings with the size of diaphragm
metastases is shown in Table 3. CT was interpreted as neg-
ative in 66.7%-80% of patients with diaphragm lesions
ranging from 1-15 mm. There was a trend towards increase
detection rate of diaphragm disease by CT with increasing
size of lesions but it did not reach significance (p = 0.529).
Single and multiple lesions were noted in 33 (55%) and 27
(45%) of patients, respectively. CT detection rate for single
metastatic lesions was 18.2% (6/33) and for multiple le-
sions was 25.9% (7/27).
Findings of pleural effusion at surgery were correlated
with preoperative CT images. The sensitivity and speci-
ficity of CT for pleural effusion was 100% (CI 95%:
72.2%-100%) and 88% (CI 95%: 76.2%-94.4%), respec-
tively. The PPV, NPV, and accuracy are shown in Table 4.
The ROC curve is drawn in Figure 2 (AUC=0.957, CI 95%:
79.9%-95.3%).
Discussion
This study is different from others [6, 8, 9] analyzing CT
findings of the entire abdomen in a single group of patients
with ovarian cancer to determine sensitivity and specificity
for optimal or suboptimal resectability. This study was di-
rected to (1) correlate only the diaphragm surgical findings
with preoperative CT diaphragm results, (2) the authors in-
cluded two groups of patients, one with and one without
diaphragm metastases, (3) CT images were not re-inter-
preted retrospectively as to reproduce daily clinical prac-
tice, and (4) the main purpose was to assist in surgical
planning instead of assessing for resectability or lack
thereof. Given that diaphragm metastases are a common
reason for incomplete debulking among gynecologic on-
cologists [10], accurate preoperative detection would be
highly beneficial to increase the rate of optimal or complete
debulkings.
Previous studies found a CT sensitivity and specificity
for diaphragm disease ranging from 48-58% and 87-100%,
respectively [8, 9]. Glaser et al. found a sensitivity of 48%
(15/31) and specificity of 100% (15/15), while Meyer et al.
[9] reported 54% sensitivity (7/13) and 87% specificity
(13/15).
Studies have found the combination of diaphragm metas-
tases with other CT findings highly predictable of the sur-
gical effort. In combination with ascites are predictors of
incomplete debulking (specificity 80%; PPV 76.9%) [7];
in association with ascites and deep peritoneal thickening
are also predictors of suboptimal debulking (sensitivity
Figure 1. — ROC curve for CT diaphragm evaluation. ROC: re-
ceiver operating characteristic; CI: confidence interval.
Figure 2. — ROC curve for CT pleural effusions evaluation.
ROC: receiver operating characteristic; CI: confidence interval.
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44% and specificity 95%) [6], and in combination with
omental cake are highly predictive for tumor dissemination
and thus a high likelihood of extensive surgery [8].
In this study CT images were not re-examined retro-
spectively to reproduce daily clinical practice, at a differ-
ence from other studies where they were re-reviewed but
without knowledge of operative findings [6-9]. Th present
authors determined CT sensitivity in patients with known
diaphragm disease, while specificity was analyzed in pa-
tients with surgically negative diaphragms. CT sensitiv-
ity was very low 28% (CI 95%: 18.5%-40.8%) while
specificity was very high 100%. Also, the AUC are close
to the lower limit for a diagnostic test. This may be due to
the lack of re-interpretation of the CT scans, the non-
bulky disease of many diaphragmatic lesions, or the
“sandwich” effect of lesions adherent to both diaphragm
and liver. The location (right, left, or both diaphragms),
number (single or multiple), and size of the metastatic le-
sions did not impact on sensitivity. In contrast, CT was
found to be highly sensitive for the detection of pleural
effusion among the 60 patients with diaphragm metas-
tases, 100% (CI 95%: 72.2%-100%), while specificity
was 88%, and the AUC are close to 1 indicating the best
result for a diagnostic test. Glasser et al. reported a simi-
lar specificity 87% (13/15) but a lower sensitivity of 65%
(20/31).
MDCT is multidetector CT is the technique of choice for
evaluating the presence of peritoneal metastases, with in-
creased accuracy over single CT [11, 12]. Although FDG-
PET/CT has a similar accuracy as CT in the preoperative
evaluation of patients suspected of EOC, it is preferred for
monitoring the therapeutic response and disease recurrence
after initial documentation of disease [12]. PET-CT has
been demonstrated to be useful for the diagnosis of node
metastases, but is limited for the detection of peritoneal im-
plants less than 10 mm, therefore not recommended for pre-
operative work up [13].
Whole-body diffusion-weighed MRI (WB-DWI/MRI)
has also been proposed as a preoperative diagnostic tool for
resectability [13]. Among its advantages are good inter-ob-
server agreement and improved detection of peritoneal
metastases and retroperitoneal nodal disease when com-
pared to CT.
Potential limitations of this study, in addition to its retro-
spective nature, must be acknowledged when interpreting
results. The diameter, not the thickness of the lesions, was
used in the analysis, which may lower sensitivity and,
therefore, superficial implants may remain undetected. In
patients with multiple metastases, the overall size of the re-
sected lesions was accounted for instead of the single
largest lesion.
In conclusion, preoperative CT has a low sensitivity and
high specificity for the detection of diaphragm metastases
in EOC. The size, location, and number of diaphragm le-
sions do not influence CT detection rate.
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